Emerging studies suggest this peptide, a dual stimulator targeting both the gut-brain axis and glucose-dependent insulinotropic polypeptide , could offer a notable development for obesity loss . https://getretatrutideaustralia.com/blog/retatrutide-vs-tirzepatide-semaglutide